The results of a randomized, controlled clinical study involving 139 patients with Meibomian Gland Dysfunction (MGD), to be published in the April 2012 issue of Cornea, compared results for treatment of MGD with the LipiFlow® Thermal Pulsation System from TearScience versus warm compress.

Treatment with LipiFlow® provided sustained improvement, on average, in both signs and symptoms.

Further, the study demonstrated the clinical utility, safety and effectiveness of LipiFlow® in adult patients with MGD and dry eye symptoms.

Click here ^[1] for further details on the study.

LipiFlow®, which applies heat and gentle pressure to a patient’s eyelid, is designed to liquefy and evacuate obstructions in Meibomian glands during a 12-minute in-office procedure. The goal of unblocking the glands is to allow them to resume their natural production of lipids required for a healthy tear film. LipiFlow®’s second generation product allows physicians to treat two eyes simultaneously ^[2].